Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: A preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention

European Radiology

Volumn 24, Issue 1, 2014, Pages 112-119

  Saito, Kazuhiro ^a   Ledsam, Joseph ^b   Sourbron, Steven ^b   Hashimoto, Tsuyoshi ^a   Araki, Yoichi ^a   Akata, Soichi ^a   Tokuuye, Koichi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Galactosyl human serum albumin scintigraphy; Gd EOB DTPA; Indocyanine green retention; Liver functional reserve; Tracer kinetic modelling

Indexed keywords

GADOLINIUM; GADOXETIC ACID; GLUTATHIONE TRANSFERASE TC 99M; HUMAN SERUM ALBUMIN; INDOCYANINE GREEN; PENTETATE TECHNETIUM TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DRUG RETENTION; EXTRACELLULAR SPACE; FEMALE; HEART; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RESECTION; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOACTIVITY; RETROSPECTIVE STUDY; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; COLORING AGENTS; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84890431550     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2983-y     Document Type: Article

References (50)

1. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255-1259
2. Manizate F, Hiotis SP, Labow D, Roayaie S, Schwartz M (2010) Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective. J Hepatobiliary Pancreat Sci 17:385-388
3. Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-470
4. Stadalnik RC, Vera DR, Woodle ES et al (1985) Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med 26:1233-1242
5. Vera DR, Krohn KA, Scheibe PO, Stadalnik RC (1985) Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng 32:312-322
6. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO (1984) Tc-99m-galactosyl- neoglycoalbumin: in vivo characterization of receptormediated binding to hepatocytes. Radiology 151:191-196
7. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO (1984) Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptormediated binding. J Nucl Med 25:779-787
8. Vera DR, Stadalnik RC, Krohn KA (1985) Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies. J Nucl Med 26:1157-1167
9. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229:409-414
10. Baxter S, Wang ZJ, Joe BN, Qayyum A, Taouli B, Yeh BM (2009) Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: initial experience. J Magn Reson Imaging 29:1317-1322
11. Blomley MJ, Coulden R, Dawson P et al (1995) Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 19:424-433
12. Hagiwara M, Rusinek H, Lee VS et al (2008) Advanced liver fibrosis: diagnosiswith 3Dwhole-liver perfusion MR imaging-initial experience. Radiology 246:926-934
13. Koh TS, Thng CH, Hartono S et al (2009) Dynamic contrastenhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling. Eur Radiol 19:1184-1196
14. Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405-411
15. Ryeom HK, Kim SH, Kim JYet al (2004) Quantitative evaluation of liver function with MRI using Gd-EOB-DTPA. Korean J Radiol 5:231-239
16. Thng CH, Koh TS, Collins DJ, Koh DM (2010) Perfusion magnetic resonance imaging of the liver.World J Gastroenterol 16:1598-1609
17. Van Beers BE, Leconte I,Materne R, Smith AM, Jamart J, Horsmans Y (2001) Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 176:667-673
18. Godfrey EM, Mannelli L, Griffin N, Lomas DJ (2013) Magnetic resonance elastography in the diagnosis of hepatic fibrosis. Semin Ultrasound CT MR 34:81-88
19. Herold C, Reck T, Fischler P et al (2002) Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre. Liver 22:23-28
20. Nagasue N, Kohno H, Chang YC et al (1993) Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217:375-384
21. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K (1984) Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 95:586-592
22. Truant S, Oberlin O, Sergent G et al (2007) Remnant liver volume to body weight ratio>or =0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204:22-33
23. Iimuro Y, Kashiwagi T, Yamanaka J et al (2010) Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/ 99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci 17:673-681
24. Kaibori M, Ha-Kawa SK, Maehara M et al (2011) Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med 25:593-602
25. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 41:99-128
26. Kashiwagi T, Yutani K, Fukuchi M et al (2002) Correction of nonuniform attenuation and image fusion in SPECT imaging by means of separate X-ray CT. Ann Nucl Med 16:255-261
27. Ichikawa T, Saito K, Yoshioka N et al (2010) Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 45:133-141
28. Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59-67
29. Clement O, Siauve N, Lewin M, de Kerviler E, Cuenod CA, Frija G (1998) Contrast agents in magnetic resonance imaging of the liver: present and future. Biomed Pharmacother 52:51-58
30. Nilsson H, Nordell A, Vargas R, Douglas L, Jonas E, Blomqvist L (2009) Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI. J Magn Reson Imaging 29:1323-1331
31. Saito K, Ledsam J, Sourbron S et al (2012) Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. J Magn Reson Imaging 37:1109-1114
32. Sourbron S, Sommer WH, Reiser MF, Zech CJ (2012) Combined quantification of liver perfusion and functionwith dynamic gadoxetic acid-enhanced MR imaging. Radiology 263:874-883
33. Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E (2010) Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford) 12:567-576
34. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649
35. Ichida FTT, Omata M, Ichida T, Inoue K, Kamimura T, Yamada G, Hino K, Yokosuka O, Suzuki H (1996) New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 6:112-119
36. Watanabe H, Kanematsu M, Goshima S et al (2011) Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging-preliminary observations. Radiology 259:142-150
37. Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1-7
38. Pedersen M, Shi Y, Anderson P et al (2004) Quantitation of differential renal blood flow and renal function using dynamic contrastenhanced MRI in rats. Magn Reson Med 51:510-517
39. Ha-Kawa SK, Tanaka Y, Hasebe S et al (1997) Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J NuclMed 24:130-137
40. Koizumi K, Uchiyama G, Arai T, Ainoda T, Yoda Y (1992) A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: evaluation of the validity of several functional parameters. Ann Nucl Med 6:83-87
41. Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298-304
42. Burgess JB, Baenziger JU, Brown WR (1992) Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 15:702-706
43. Hwang EH, Taki J, Shuke N et al (1999) Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 40:1644-1651
44. Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T,Matsui Y, Kamiyama Y (1997) Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 25:426-429
45. Kwon AH, Matsui Y, Kaibori M, Ha-Kawa SK (2006) Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery 140:379-386
46. Mastai R, Laganiere S, Wanless IR, Giroux L, Rocheleau B, Huet PM (1996) Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies.Hepatology 24:865-870
47. Iguchi T, Sato S, Kouno Yet al (2003) Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy. Ann Nucl Med 17:227-233
48. Van Beers BE, Materne R, Annet L et al (2003) Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrastenhanced MRI in the rabbit. Magn Reson Med 49:692-699
49. Nguyen-Khac E, Lobry C, Chatelain D et al (2013) A reappraisal of chemotherapy-induced liver injury in colorectal liver metastases before the era of antiangiogenics. Int J Hepatol 2013:314868
50. Shaib YH, El-Serag HB, Nooka AK et al (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 102:1016-1021